TBX21 and colorectal carcinoma: Utilizing publicly available data from four data repositories, including 15 datasets, 2391 CRC patients, and 7 omics datasets, we found a difference in survival based on differential expression and methylation of the critical T cell regulatory factor T-bet (TBX21).